Yes, beta hCG levels can be an important marker for monitoring the effectiveness of cancer treatment. For instance, decreasing levels of beta hCG can indicate that the treatment is working, while increasing levels may suggest a recurrence of the disease. Regular monitoring of beta hCG helps in adjusting treatment plans and improving patient outcomes.
